Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Healthcare (Basel, Switzerland)
|
June 2, 2021
Ixekizumab May Improve Renal Function in Psoriasis
Giuseppe Fabrizio Amoruso, Steven Paul Nisticò, Luigi Iannone, et al.
Medicina (Kaunas, Lithuania)
|
November 25, 2023
An Innovative Dual-Wavelength Laser Technique for Atrophic Acne Scar Management: A Pilot Study
Stefania Belletti, Francesca Madeddu, Giuseppe Fabrizio Amoruso, et al.
Photobiomodulation, Photomedicine, and Laser Surgery
|
January 15, 2021
A New 675 nm Laser Device in the Treatment of Facial Aging: A Prospective Observational Study
Giovanni Cannarozzo, Gilda Fazia, Luigi Bennardo, et al.
Biomedicines
|
June 28, 2023
Risankizumab: Daily Practice Experience of High Need Patients
Alexandra M G Brunasso, Martina Burlando, Fabrizio Amoruso, et al.
Acta Dermatovenerologica Croatica : ADC
|
August 2, 2018
Neurodystrophic Hand Dermatitis: Sannino Barduagni Syndrome
Ugo Bottoni, Stefania Tamburrini, Elisabetta Scali, et al.
Dermatologic Therapy
|
May 31, 2022
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)
Piergiorgio Malagoli, Paolo Dapavo, Giulia Pavia, et al.
Journal of the American Academy of Dermatology
|
July 24, 2024
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study
Elena Pezzolo, Alessandra Narcisi, Luigi Gargiulo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2022
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, et al.
American Journal of Clinical Dermatology
|
March 16, 2021
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Longo, et al.
Journal of Clinical Medicine
|
January 23, 2024
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis
Elena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Healthcare (Basel, Switzerland)
|
June 2, 2021
Ixekizumab May Improve Renal Function in Psoriasis
Giuseppe Fabrizio Amoruso, Steven Paul Nisticò, Luigi Iannone, et al.
Medicina (Kaunas, Lithuania)
|
November 25, 2023
An Innovative Dual-Wavelength Laser Technique for Atrophic Acne Scar Management: A Pilot Study
Stefania Belletti, Francesca Madeddu, Giuseppe Fabrizio Amoruso, et al.
Photobiomodulation, Photomedicine, and Laser Surgery
|
January 15, 2021
A New 675 nm Laser Device in the Treatment of Facial Aging: A Prospective Observational Study
Giovanni Cannarozzo, Gilda Fazia, Luigi Bennardo, et al.
Biomedicines
|
June 28, 2023
Risankizumab: Daily Practice Experience of High Need Patients
Alexandra M G Brunasso, Martina Burlando, Fabrizio Amoruso, et al.
Acta Dermatovenerologica Croatica : ADC
|
August 2, 2018
Neurodystrophic Hand Dermatitis: Sannino Barduagni Syndrome
Ugo Bottoni, Stefania Tamburrini, Elisabetta Scali, et al.
Dermatologic Therapy
|
May 31, 2022
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)
Piergiorgio Malagoli, Paolo Dapavo, Giulia Pavia, et al.
Journal of the American Academy of Dermatology
|
July 24, 2024
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study
Elena Pezzolo, Alessandra Narcisi, Luigi Gargiulo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2022
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, et al.
American Journal of Clinical Dermatology
|
March 16, 2021
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Longo, et al.
Journal of Clinical Medicine
|
January 23, 2024
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis
Elena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, et al.
Page
of 2